Sector News

Medtronic appoints Madan Krishnan as VP Indian Sub-continent

September 8, 2016
Life sciences

Global medical technology major Medtronic plc has appointed Madan Krishnan as Vice President for Indian sub-continent.

In this role, Krishnan will lead the Medtronic Indian sub-continent business (ISC), which includes India, Sri Lanka, Bangladeshand Nepal, Medtronic plc said in a statement.

Commenting on the development, Medtronic AsiaPacific President Bob White said: “”We see tremendous growth potential in ISC and I have full confidence in Madan’s ability to be an engaged and collaborative industry leader while caring for our employees.”

Krishnan joined Medtronic in 2011. Prior to this appointment, Krishnan was vice president of finance, AsiaPacific (APAC).

Medtronic began its operations in Indiain 1979. Headquartered in Mumbai, the company has offices at Ahmedabad, Bengaluru, Chennai, Cochin, Dhaka, Gurgaon, Hyderabad, Kolkata, New Delhi, Puneand Vadodara.

Source: Business Standard

comments closed

Related News

October 2, 2022

GSK names Julie Brown, a 25-year AstraZeneca veteran, its first woman CFO

Life sciences

Five years ago, GSK made headlines when it hired Emma Walmsley to become the first woman to run a major pharmaceutical company. Now the Big Pharma has brought in another woman to control the company’s finances. Julie Brown will be GSK’s next chief financial officer. Brown, currently the chief operating and financial officer at fashion and beauty brand Burberry Group, is set to replace Iain Mackay.

October 2, 2022

Moderna creates new launch preparation role, poaches Novartis exec as manufacturing lead

Life sciences

Moderna created a new role responsible for “building out the company’s organization to support its growing pipeline.” Starting first thing 2023, Juan Andres, Moderna’s manufacturing head, will step into this new role under the title president of strategic partnerships and enterprise expansion, the company said Thursday.

October 2, 2022

Torrent Pharma to acquire Curatio for $245.16m

Life sciences

The latest takeover is anticipated to boost the presence of Torrent in the dermatology segment. Indian company Torrent Pharmaceuticals has signed a definitive agreement for the complete acquisition of Curatio Healthcare for $245.16m (Rs20bn).